Journal Of Medical Economics

Journal Of Medical Economics

医学经济学杂志

  • 4区 中科院分区
  • Q1 JCR分区

期刊简介

《Journal Of Medical Economics》是由Taylor and Francis Ltd.出版社于1991年创办的英文国际期刊(ISSN: 1369-6998,E-ISSN: 1941-837X),该期刊长期致力于医学:内科领域的创新研究,主要研究方向为HEALTH CARE SCIENCES & SERVICES-MEDICINE, GENERAL & INTERNAL。作为SCIE收录期刊(JCR分区 Q1,中科院 4区),本刊采用OA未开放获取模式(OA占比0.1741...%),以发表医学:内科领域等方向的原创性研究为核心(研究类文章占比91.61%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在143篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Journal Of Medical Economics审稿周期约为 。该刊近年未被列入国际预警名单,年发文量约143篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 143 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
MEDICINE, GENERAL & INTERNAL 医学:内科 HEALTH CARE SCIENCES & SERVICES 卫生保健与服务
3区 4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
MEDICINE, GENERAL & INTERNAL 医学:内科 HEALTH CARE SCIENCES & SERVICES 卫生保健与服务
3区 4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:HEALTH CARE SCIENCES & SERVICES SCIE Q2 54 / 174

69.3%

学科:MEDICINE, GENERAL & INTERNAL SCIE Q1 64 / 325

80.5%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:HEALTH CARE SCIENCES & SERVICES SCIE Q2 51 / 175

71.14%

学科:MEDICINE, GENERAL & INTERNAL SCIE Q1 57 / 329

82.83%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:4.5 SJR:0.988 SNIP:0.942
学科类别 分区 排名 百分位
大类:Medicine 小类:Health Policy Q2 85 / 310

72%

期刊发文

  • Targeted literature review of the burden of extraintestinal pathogenic Escherichia Coli among elderly patients in Asia Pacific regions

    Author: Ohmagari, Norio; Choi, Won Suk; Tang, Hung-Jen; Atanasov, Petar; Jiang, Xiaobin; Pastor, Luis Hernandez; Nakayama, Yoshikazu; Chiang, Jason; Lim, Kyunghwa; Nievera, Maria Carmen

    Journal: JOURNAL OF MEDICAL ECONOMICS. 2023; Vol. 26, Issue 1, pp. 168-178. DOI: 10.1080/13696998.2023.2169447

  • Evaluation of health economic impact of initial diagnostic modality selection for colorectal cancer liver metastases in suspected patients in China, Japan and the USA

    Author: Blankenburg, Michael; Elhamamy, Mostafa; Zhang, Diana; Fujikawa, Naoto; Corbin, Alice; Jin, Guanyi; Harris, James; Knobloch, Gesine

    Journal: JOURNAL OF MEDICAL ECONOMICS. 2023; Vol. 26, Issue 1, pp. 219-232. DOI: 10.1080/13696998.2023.2173436

  • Does an economic incentive affect provider behavior? Evidence from a field experiment on different payment mechanisms.

    Author: Xi X1, Wang E1, Lu Q1, Chen P1, Wo T1, Tang K1.

    Journal: J Med Econ. 2019 Jan;22(1):35-44. doi: 10.1080/13696998.2018.1539399. Epub 2018 Nov 15.

  • Constructing a value-based healthcare system for hypertensive patients through changing payment mode: evidence from a comparative study in rural China.

    Author: Miao Y1,2, Yuan X3, Gu J1, Zhang L4, He R4, Sandeep S4, Wu J5.

    Journal: J Med Econ. 2019 Mar;22(3):245-251. doi: 10.1080/13696998.2018.1558864. Epub 2019 Jan 17.

  • Real-world evidence of improved healthcare utilization in patients with schizophrenia or schizoaffective disorder after early treatment of paliperidone palmitate once-monthly treatment in Hong Kong.

    Author: Choon JWY1, Wu DBC1,2, Chong HY1, Lo WTL3, Chong CSY3, Chung WS4, Chui EMC5, Tomlinson B6, Lee VWY7, Lee SC6, Lee KKC1.

    Journal: J Med Econ. 2019 Mar;22(3):273-279. doi: 10.1080/13696998.2018.1560749. Epub 2019 Jan 14.

  • Cost-effectiveness analysis of first-line pembrolizumab treatment for PD-L1 positive, non-small cell lung cancer in China.

    Author: Liao W1,2, Huang J1,2, Hutton D3, Li Q1,2.

    Journal: J Med Econ. 2019 Apr;22(4):344-349. doi: 10.1080/13696998.2019.1570221. Epub 2019 Feb 6.

  • Cost-effectiveness analysis of dapagliflozin treatment versus metformin treatment in Chinese population with type 2 diabetes.

    Author: Cai X1, Shi L2, Yang W1, Gu S3, Chen Y4, Nie L5, Ji L1.

    Journal: J Med Econ. 2019 Apr;22(4):336-343. doi: 10.1080/13696998.2019.1570220. Epub 2019 Feb 4.

  • Cost-effectiveness of olanzapine in the first-line treatment of schizophrenia in China.

    Author: Zhao J1, Jiang K2, Li Q3, Zhang Y4, Cheng Y4, Lin Z5, Xuan J6.

    Journal: J Med Econ. 2019 May;22(5):439-446. doi: 10.1080/13696998.2019.1580714. Epub 2019 Mar 5.